entertainment -WSS

entertainment

author：explore 2025-09-30 00:50:13 - browse：5

STAT's Casey Ross (left) and Kimberly Powell, NVIDIA's vice president for healthcare at the STAT Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

SAN FRANCISCO — In the world of drug discovery, AI progress is often measured by a single-mile marker: When will we get an AI-designed drug?

The answer remains, ambiguously, “the future,” but at STAT’s Breakthrough Summit leaders from NVIDIA and Google insisted that the impact of AI is visible today.

Kimberly Powell, vice president of healthcare for NVIDIA, pointed to an increase in investigational new drug applications filed with the Food and Drug Administration that cite AI, as well as an uptick in early-stage readouts from clinical trials, as evidence of progress. Some of the recent readouts, Powell said, show that what’s going into Phase 1 clinical trials is more successful.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： People with mental disorders often marry others with same

explore

WSS

Reconstructing family trees of blood cells may help predict disease

Insurer loopholes limit power of law against surprise medical bills

Merck CEO won’t testify in Senate, citing no expertise in drug prices

Mass General Brigham physicians react to latest merger step

Republican states more likely to report Covid vaccine side effects

Pancreatic cancer is often deadly, but new discoveries are raising hope

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

Bernie Sanders is gearing up to subpoena pharma CEOs

New air purifier tech could be key to improving indoor air quality

Pancreatic cancer is often deadly, but new discoveries are raising hope

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Four alarming medical procedures we’re glad history forgot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Wegovy leads to weight loss. Can it treat depression, too?

23andMe had bad news about my health. I wish a person had delivered it

People with mental disorders often marry others with same

knowledge

Study: Black kids more likely to die after surgery than white kids

Boston competes with Raleigh

Drug companies' payments and gifts affect physicians' prescribing

Four alarming medical procedures we’re glad history forgot

The latest on Bluebird gene therapies, Vertex's pain drug, and ADC FOMO

Scientists uncover potential path to treating deadly childhood tumor

entertainment

hotspot

explore

knowledge